CashuenCore Energy Highlights AOBiome's Progress in Phase 3 Trials for Atopic Dermatitis Treatment B2446 days ago
benzinga.comElon Musk Warns of 'Response' After X Penalty, Targets Those He Says Are Responsible2 days ago
prnewswire.comAOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the European Union (EU)6 days ago
prnewswire.comKuCoin EU Secures MiCAR License to Deliver Regulated Digital Asset Services In Europe10 days ago
prnewswire.comKuCoin EU Secures MiCAR License to Deliver Regulated Digital Asset Services In Europe10 days ago
prnewswire.comSAP Unveils EU AI Cloud: A Unified Vision for Europe's Sovereign AI and Cloud Future12 days ago
prnewswire.comISX Financial EU Plc verlsst die National Stock Exchange of Australia (NSX Ltd)14 days ago